Tribunalo, Cesar .

HRN: 25-09-70  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2024
CO-AMOXICLAV 625MG (TAB)
05/28/2024
06/04/2024
PO
625mg
Q8hrs
Lacerated Wound Wrist, Right; S/p Wound Exploration And Suturing
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: